학술논문

P39 DEDALO: PHASE II STUDY OF DARATUMUMAB PLUS POMALIDOMIDE AND DEXAMETHASONE (DPD) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AND 17P DELETION.
Document Type
Abstract
Source
HemaSphere; May2023 Supplement S2, Vol. 7, p32-33, 2p
Subject
Language
ISSN
25729241